Article info

Download PDFPDF

IL-6 modulation for COVID-19: the right patients at the right time?

Authors

  • Paolo Antonio Ascierto Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy PubMed articlesGoogle scholar articles
  • Binqing Fu Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Science and Medical Center; Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China PubMed articlesGoogle scholar articles
  • Haiming Wei Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Science and Medical Center; Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China PubMed articlesGoogle scholar articles

Citation

Ascierto PA, Fu B, Wei H
IL-6 modulation for COVID-19: the right patients at the right time?
Online issue publication 
May 06, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.